Hint mode is switched on Switch off
For swift navigation between sections

Pentixapharm Holding
LEI 3912005VBOVXNDXEQZ36

PDF download

Choose all Reset all
Download Cancel
Organization name
Pentixapharm Holding AG
Country name
Germany
Country of registration
Germany
Industry
Medical Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Pentixapharm Holding AG operates as a holding company. The Company, through its subsidiaries, focuses on developing CXCR4 ligand-based radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    3912005VBOVXNDXEQZ36
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.